144 related articles for article (PubMed ID: 15212643)
1. The sodium-iodide symporter protein is always present at a low expression and confined to the cell membrane in nonfunctioning nonadenomatous nodules of toxic nodular goitre.
Tonacchera M; Viacava P; Fanelli G; Agretti P; De Marco G; De Servi M; Di Cosmo C; Chiovato L; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2004 Jul; 61(1):40-5. PubMed ID: 15212643
[TBL] [Abstract][Full Text] [Related]
2. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the sodium iodide symporter expression in histological slides from a nodular goiter.
Syrenicz A; Wolny M; Kram A; Sworczak K; Syrenicz M; Garanty-Bogacka B; Walczak M
Arch Med Res; 2007 Feb; 38(2):219-26. PubMed ID: 17227732
[TBL] [Abstract][Full Text] [Related]
4. Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter.
Tonacchera M; Agretti P; Chiovato L; Rosellini V; Ceccarini G; Perri A; Viacava P; Naccarato AG; Miccoli P; Pinchera A; Vitti P
J Clin Endocrinol Metab; 2000 Jun; 85(6):2270-4. PubMed ID: 10852462
[TBL] [Abstract][Full Text] [Related]
5. Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma.
Tonacchera M; Chiovato L; Pinchera A; Agretti P; Fiore E; Cetani F; Rocchi R; Viacava P; Miccoli P; Vitti P
J Clin Endocrinol Metab; 1998 Feb; 83(2):492-8. PubMed ID: 9467563
[TBL] [Abstract][Full Text] [Related]
6. Alterations of NIS expression in functioning thyroid nodules.
Gözü HI; Yavuzer D; Kaya H; Vural S; Sargın H; Gezen C; Sargın M; Akalın S
Kulak Burun Bogaz Ihtis Derg; 2010; 20(6):285-92. PubMed ID: 20961282
[TBL] [Abstract][Full Text] [Related]
7. Role of basic fibroblast growth factor in the pathogenesis of nodular goiter.
Gärtner R; Veitenhansl M; Aktas J; Schopohl D
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():36-8. PubMed ID: 8980998
[TBL] [Abstract][Full Text] [Related]
8. Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter.
Russo D; Bulotta S; Bruno R; Arturi F; Giannasio P; Derwahl M; Bidart JM; Schlumberger M; Filetti S
Eur J Endocrinol; 2001 Nov; 145(5):591-7. PubMed ID: 11720877
[TBL] [Abstract][Full Text] [Related]
9. [Mutations in the thyrotropin receptor gene in the pathogenesis of toxic thyroid adenomas, toxic goiter nodules and autosomal dominant hyperthyroidism].
Derwahl M
Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():25-8. PubMed ID: 10355046
[TBL] [Abstract][Full Text] [Related]
10. Functioning and nonfunctioning thyroid adenomas involve different molecular pathogenetic mechanisms.
Tonacchera M; Vitti P; Agretti P; Ceccarini G; Perri A; Cavaliere R; Mazzi B; Naccarato AG; Viacava P; Miccoli P; Pinchera A; Chiovato L
J Clin Endocrinol Metab; 1999 Nov; 84(11):4155-8. PubMed ID: 10566665
[TBL] [Abstract][Full Text] [Related]
11. hNIS protein in thyroid: the iodine supply influences its expression and localization.
Scipioni A; Ferretti E; Soda G; Tosi E; Bruno R; Costante G; Meringolo D; Arturi F; Durante C; Amorosi A; Foschini MP; Nardi F; Russo D; Filetti S
Thyroid; 2007 Jul; 17(7):613-8. PubMed ID: 17696829
[TBL] [Abstract][Full Text] [Related]
12. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization.
Dayem M; Basquin C; Navarro V; Carrier P; Marsault R; Chang P; Huc S; Darrouzet E; Lindenthal S; Pourcher T
J Endocrinol; 2008 Apr; 197(1):95-109. PubMed ID: 18372236
[TBL] [Abstract][Full Text] [Related]
13. The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study.
Di Cosmo C; Fanelli G; Tonacchera M; Ferrarini E; Dimida A; Agretti P; De Marco G; Vitti P; Pinchera A; Bevilacqua G; Naccarato AG; Viacava P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):544-8. PubMed ID: 16984250
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms.
Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW
Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653
[TBL] [Abstract][Full Text] [Related]
15. Low Iodine in the Follicular Lumen Caused by Cytoplasm Mis-localization of Sodium Iodide Symporter may Induce Nodular Goiter.
Huang H; Shi Y; Liang B; Cai H; Cai Q
Biol Trace Elem Res; 2017 Oct; 179(2):165-171. PubMed ID: 28190186
[TBL] [Abstract][Full Text] [Related]
16. [Functional microscopic imaging of the thyroid gland with the help of analytical ion microscopy].
Fragu P; Halpern S; Briançon C; Olivo JC; Kahn E
Pathol Biol (Paris); 1991 Dec; 39(10):1029-37. PubMed ID: 1805136
[TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules.
Vannelli GB; Barni T; Modigliani U; Paulin I; Serio M; Maggi M; Fiorelli G; Balboni GC
J Clin Endocrinol Metab; 1990 Nov; 71(5):1175-82. PubMed ID: 2172274
[TBL] [Abstract][Full Text] [Related]
18. Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter.
Tonacchera M; Vitti P; Agretti P; Giulianetti B; Mazzi B; Cavaliere R; Ceccarini G; Fiore E; Viacava P; Naccarato A; Pinchera A; Chiovato L
Thyroid; 1998 Jul; 8(7):559-64. PubMed ID: 9709907
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatocyte growth factor in Hashimoto's thyroiditis with nodular lesions.
Ruggeri RM; Sciacchitano S; Trimarchi F; Barresi G; Trovato M
Eur J Histochem; 2007; 51(3):193-8. PubMed ID: 17921114
[TBL] [Abstract][Full Text] [Related]
20. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
